Products with Antibacterial bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN2730 | Myristicin |
| Myristicin has anti-cholinergic, antibacterial, and hepatoprotective effects, it also has anti-inflammatory properties related with its inhibition of NO, cytokines,chemokines, and growth factors in dsRNA-stimulated macrophages via the calcium pathway. Myristicin may antagonize the anxiolytic effects of midazolam, increase anxiety, and affect motor movements. Myristicin can induce apoptosis as characterised by alterations in the mitochondrial membrane potential, cytochrome c release, caspase-3 activation, PARP-cleavage and DNA fragmentation. | |
| BCN2773 | Tomatidine |
| Tomatidine shows antibiotic, and anti-inflammatory activities, it significantly suppresses the activity of ACAT and leads to reduction of atherogenesis. Tomatidine inhibits the invasion of A549 cells by reducing the expression of MMPs, also inhibits ERK and Akt signaling pathways and NF-κB activity, suggests a new therapeutic potential for Tomatidine in anti-metastatic therapy. | |
| BCN2818 | Elemicin |
| Elemicin has anticancer, and antifungal activities, it exhibits anticholinergic-like effects in humans. | |
| BCN2832 | Magnolioside |
| Magnolioside has anti-plasmodial activity, shows notable growth inhibitory activity against chloroquine-sensitive strains of P. falciparum. It also shows a moderate antibacterial activity against Staphylococcus aureus CIP 53.154. | |
| BCN2849 | 7-O-Methylaloeresin A |
| 1. 7-O-Methylaloeresin A has moderate inhibitory active on BACE. 2. 7-O-Methylaloeresin A shows significant antioxidant activity. 3. 7-O-Methylaloeresin A exhibits good activity against multiple drug resistant Staphylococcus aureus (NCTC 11994) and Salmonella typhimurium (ATCC 1255) with MIC values of 0.72 and 0.18 mm, respectively. | |
